The published study supports this mechanistic insight, showing that PS-MPs activate NR4A1 (Chiu et al., 2025), a nuclear receptor that acts upstream of AMPK signalling, contributing to an energy metabolism imbalance and hepatic steatosis. Here, PRKAA1 is linked to fatty liver disease.